-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-262-pharmacotherapy-alcohol-disposition-comments.pdf
November 07, 2023 - Page 32, line 45: Missing “placebo” from the end of the first sentence. … Expert
#4
ES Page v line 49 As a clinician I do not find contraindication to acamprosate (severe
renal … major decision maker in this section, or if it stays in, specify
that the contraindication is severe renal … should be careful to respect contraindications of each individual medication (for
acamprosate, severe renal … Public Comment
#3 (APA)
Introduction p. 4 table disulfiram Suggest changing "at the acetaldehyde stage
-
www.ahrq.gov/hai/cauti-tools/guides/implguide-pt3.html
October 01, 2015 - Assistance with healing of stage III or IV perineal and sacral wounds in incontinent patients —This is … For example, indwelling urinary catheters can be appropriate for stage III, IV, or unstageable pressure … Hospice/comfort/palliative care —This is an acceptable indication for catheter use in end-of-life care … urine output as part of routine care when admitted for certain conditions such as heart failure or renal … An exception would be for patients who are receiving end-of-life or palliative care and in whom a catheter
-
psnet.ahrq.gov/node/49843/psn-pdf
October 01, 2018 - In the end, clinicians realized that the patient had initially been misdiagnosed with sepsis and that … organ dysfunction, such as hypotension,
elevated lactate, respiratory failure, altered mental status, renal … the patient described had laboratory evidence of
inflammation (elevated white blood cell count) and end-organ … When patients present with circulatory shock or signs of end-organ dysfunction, empiric antibiotics
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
January 01, 2006 - in 2-3
doses; Extended-
release, 100-200
mg/day
RA: Delayed-
release, 100-200
mg/day in 3- 4
Renal … impairment(CrCl
>25 mL/min) max 150
mg/day;
Moderate renal impairment
(CrCl l<25 mL/min) max 100 … (Give numbers at each stage of attrition.) … : No SS difference b/t lumiracoxib and NSAIDs for renal
endpoint or serious liver AEs. … update
9/16/02
Pain reduction
2 placebo controlled trials provided pain intensity at baseline and end
-
www.ahrq.gov/patient-safety/settings/esrd/resource/cultureofsafety.html
January 01, 2015 - Creating a Culture of Safety
ESRD Toolkit
The Creating a Culture of Safety module of the ESRD Toolkit discusses the importance of a comprehensive, unit-based approach to safety and its impact on improving patient care and reducing harm in dialysis centers.
Presentation Slides ( PPTX, 20 M B)
Facilitator …
-
www.ahrq.gov/patient-safety/settings/esrd/resource/checklist.html
January 01, 2015 - Using Checklists and Audit Tools
ESRD Toolkit
The Using Checklists and Audit Tools module of the ESRD Toolkit explains the importance of using data in the quality assurance and performance improvement process, and explains how implementing checklists and audit tools aligns with the principles of safe design. …
-
hcup-us.ahrq.gov/db/nation/nrd/NRD_Introduction_2013.jsp
January 01, 2013 - Medicare patients younger than 65 include people who are disabled or who have been diagnosed with end-stage … renal disease or amyotrophic lateral sclerosis (ALS). … software packages that perform calculations for numerous statistics arising from the stratified, single-stage … Medicare patients under the age of 65 include people who are disabled or who have been diagnosed with end-stage … renal disease or amyotrophic lateral sclerosis (ALS).
-
effectivehealthcare.ahrq.gov/sites/default/files/topic-refinement.ppt
March 01, 2010 - What is the risk of renal dysfunction, hyperkalemia, cough, and angioedema associated with the use of … The second question is, “What is the risk of renal dysfunction, hyperkalemia, cough, and angioedema associated … Many surrogate/intermediate end points have not been adequately validated. … Just because there is enough information to pool a myriad of intermediate end points does not mean that … This completes the topic refinement project and sets the stage for the next phase, in which the key questions
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/We5A-uCMvX5qYeFukGgqks
March 01, 2004 - We excluded studies of pregnant patients;
children; and patients with occupational exposures,
end-stage … Clinical outcomes that we
evaluated were mortality, end-stage liver disease,
cirrhosis, and hepatocellular … We excluded studies
that focused only on patients with end-stage liver
disease, cirrhosis, or hepatocellular … undergone transplantation
were excluded, as were studies of pregnant patients,
children, or those with end-stage … renal disease or
HIV infection.
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/hepatitis-c-virus-infection-screening-2004
March 08, 2004 - We excluded studies of pregnant patients; children; and patients with occupational exposures, end-stage … Clinical outcomes that we evaluated were mortality, end-stage liver disease, cirrhosis, and hepatocellular … We excluded studies that focused only on patients with end-stage liver disease, cirrhosis, or hepatocellular … undergone transplantation were excluded, as were studies of pregnant patients, children, or those with end-stage … renal disease or HIV infection.
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary43/prostate-cancer-screening-2012
October 07, 2011 - What are the harms of treatment of early-stage or screening-detected prostate cancer? … Surveillance, Epidemiology, and End Results (SEER) program ( n =25,900) of men 65 to 80 years of age … comorbid conditions (diabetes, cardiovascular disease, respiratory disease, gastrointestinal disease, renal … 1: 29% Stage 2: 40% Stage 3: 31% PSA < 10 µg/L: 22% PSA 11–29 µg/L: 28% PSA > 30 µg/L: 23% PSA unknown … prostate-specific antigen; RCT = randomized, controlled trial; SEER = Surveillance, Epidemiology, and End
-
digital.ahrq.gov/sites/default/files/docs/citation/r13hs024833-gill-final-report-2017.pdf
January 01, 2017 - Results: By the end of Day 2, the group of stakeholder representatives and subject matter experts
produced … These talks
set the stage for development of guidelines that address the needs of these priority populations … reality include but are not limited to (i) the training of health professionals (e.g., percutaneous
renal … If recognition of biases
and defective perceptions in VR does not occur, we could end up increasing
-
psnet.ahrq.gov/perspective/conversation-sharon-k-inouye-md-mph
December 01, 2012 - tried to get them to share what they were using with me because I really viewed that as a means to an end … delirium, some of them say things like delirium following alcohol withdrawal, or delirium following renal … They're a little hyponatremic, going into renal failure, and on medications that maybe the doctor has … brain function [ 5 ]), it is worth thinking about delirium as an "acute brain injury" similar to other end-organ … As with these other important end-organ injuries, delirium is a clinical event for which prevention and
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/nmcMhEwWT9BncBBBQQN6Uf
December 01, 2015 - years, with exponential distribution using DCIS incidence data from the Surveillance,
Epidemiology and End … On the other end of the spectrum, the model
allows for another subset of tumors to be “aggressive” by … years to capture lifetime reductions
in breast cancer mortality occurring years after the start (and end … Surveillance, Epidemiology and End Results Program (SEER):
SEER*Stat Software. … )vascular disease; paralysis; diabetes 12% 13
Severe AIDS; mild or severe liver disease; chronic
renal
-
www.uspreventiveservicestaskforce.org/Home/GetFile/1/16255/collabmodelingbc/pdf
December 01, 2015 - years, with exponential distribution using DCIS incidence data from the Surveillance,
Epidemiology and End … On the other end of the spectrum, the model
allows for another subset of tumors to be “aggressive” by … years to capture lifetime reductions
in breast cancer mortality occurring years after the start (and end … Surveillance, Epidemiology and End Results Program (SEER):
SEER*Stat Software. … )vascular disease; paralysis; diabetes 12% 13
Severe AIDS; mild or severe liver disease; chronic
renal
-
digital.ahrq.gov/sites/default/files/docs/page/findings-and-lessons-from-clinical-decision-support-demonstration-projects.pdf
June 01, 2014 - Most directly, one of the Stage 1 objectives is for
providers to “implement one clinical decision support … CDS-related
objectives for Stage 1 meaningful use include the following:
• Capturing clinical data … specialty or high clinical
priority along with the ability to track compliance with that rule.3
Stage … could lead to
conflicting clinical recommendations (e.g., a patient with diabetes, heart failure, and renal … Although the use of CDS is a core measure for all stages,
meaningful use Stage 3 is expected to have
-
cds.ahrq.gov/sites/default/files/cds/artifact/26/Implementation%20Guide_USPSTF%20Aspirin%20Therapy%20for%20the%20Prevention%20of%20CVD%20and%20CRC_Final.docx
October 01, 2017 - Patient has end-stage renal disease.
e. Patient is on another anticoagulant.
f. … Figure 1: CDS Artifact Maturity Process
To continue the maturation of this artifact to the structured stage … Diagnosis of GI bleed
OR Diagnosis of GI ulcers
OR Diagnosis of bleeding disorders
OR Diagnosis of renal
-
digital.ahrq.gov/sites/default/files/docs/citation/ereferralimplementationreportfinal.pdf
February 01, 2012 - next patient. 64.4
percent (203) complete the electronic referral AFTER patient visits, e.g., at the end … think some people have been less eager to adopt it because it takes a little bit
longer on the front end … It used to just be every
referral got at the end of the line. … The design team considered
workflow at the system development stage. … End Points. An end point is the event by which a process is deemed completed.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-adherence_research-protocol.pdf
September 13, 2011 - population includes patients for whom
treatment is contraindicated:
Pregnant women
Patients with renal … We will code the reason any articles, at the stage of the full-text review, are not
included in the … Studies at the abstract and full-review stage will be managed with
Reference Manager so that we can … Because of their role as end-users,
individuals are invited to serve as Key Informants and those who … population
include patients for whom treatment is
contraindicated:
Pregnant women
Patients with renal
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-2015.pdf
January 01, 2015 - payers
have also broadened the eligibility for treatment to include infected individuals with earlier stage … Lymphomas
Intranasal Oxytocin for Social Dysfunction in Autism Spectrum Disorders
Catheter-Based Renal … some third-party payers is to treat only those patients in advanced
10
stages of infection (stage … When added to standard intraoperative
assessment during lumpectomy for early stage breast cancer, MarginProbe … Care System for
Preserving Donor
Lungs
A double-lung transplant is a last resort for patients with end-stage